Cargando…

Bone health in phenylketonuria: a systematic review and meta-analysis

Patients with Phenylketonuria (PKU) reportedly have decreased bone mineral density (BMD). The primary aim of this study was to perform a systematic review and meta-analysis to determine the extent and significance of low BMD in early treated patients with PKU. Secondary aims were to assess other bon...

Descripción completa

Detalles Bibliográficos
Autores principales: Demirdas, Serwet, Coakley, Katie E, Bisschop, Peter H, Hollak, Carla E M, Bosch, Annet M, Singh, Rani H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340652/
https://www.ncbi.nlm.nih.gov/pubmed/25758373
http://dx.doi.org/10.1186/s13023-015-0232-y
_version_ 1782359047589068800
author Demirdas, Serwet
Coakley, Katie E
Bisschop, Peter H
Hollak, Carla E M
Bosch, Annet M
Singh, Rani H
author_facet Demirdas, Serwet
Coakley, Katie E
Bisschop, Peter H
Hollak, Carla E M
Bosch, Annet M
Singh, Rani H
author_sort Demirdas, Serwet
collection PubMed
description Patients with Phenylketonuria (PKU) reportedly have decreased bone mineral density (BMD). The primary aim of this study was to perform a systematic review and meta-analysis to determine the extent and significance of low BMD in early treated patients with PKU. Secondary aims were to assess other bone status indicators including bone turnover markers (BTM) and to define areas for future research. Two research teams (Amsterdam, Netherlands and Atlanta, USA) performed literature searches for articles reporting data on BMD, osteopenia and osteoporosis, BTM or other bone indicators in patients with PKU. Included articles were compared between research teams and assessed for quality and risk of bias. A total of 13 unique articles were included; 11/13 articles reported BMD including a total of 360 patients. Ten out of 11 articles found BMD was significantly lower in patients with PKU. Meta-analyses for total BMD (TBMD; 3 studies; n = 133), lumbar spine BMD (LBMD; 7 studies; n = 247), and femoral neck BMD (FBMD; 2 studies; n = 78) Z-scores were performed. Overall effect sizes were: TBMD −0.45 (95% CI −0.61, −0.28); LBMD −0.70 (95% CI −0.82, −0.57); FBMD −0.96 (95% CI −1.42, −0.49). Definitions of osteopenia and osteoporosis were highly heterogeneous between studies and did not align with World Health Organization standards and the International Society for Clinical Densitometry positions on BMD measurement. Despite individual study findings of low BMD indicating higher risk of osteoporosis, pooled available data suggest reduction in BMD is not clinically important when using standard definitions of low BMD. Results from studies evaluating BTM are inconclusive. Phenylalanine concentration, vitamin D, PTH, and nutrient intake do not correlate with BMD or BTM. We recommend forthcoming studies use standard definitions of low BMD to determine clinical implications of BMD Z-scores below 0, explore cause of low BMD in the subset of patients with low BMD for chronological age (Z-score < −2) and assess fracture risk in patients with PKU. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13023-015-0232-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4340652
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43406522015-02-26 Bone health in phenylketonuria: a systematic review and meta-analysis Demirdas, Serwet Coakley, Katie E Bisschop, Peter H Hollak, Carla E M Bosch, Annet M Singh, Rani H Orphanet J Rare Dis Review Patients with Phenylketonuria (PKU) reportedly have decreased bone mineral density (BMD). The primary aim of this study was to perform a systematic review and meta-analysis to determine the extent and significance of low BMD in early treated patients with PKU. Secondary aims were to assess other bone status indicators including bone turnover markers (BTM) and to define areas for future research. Two research teams (Amsterdam, Netherlands and Atlanta, USA) performed literature searches for articles reporting data on BMD, osteopenia and osteoporosis, BTM or other bone indicators in patients with PKU. Included articles were compared between research teams and assessed for quality and risk of bias. A total of 13 unique articles were included; 11/13 articles reported BMD including a total of 360 patients. Ten out of 11 articles found BMD was significantly lower in patients with PKU. Meta-analyses for total BMD (TBMD; 3 studies; n = 133), lumbar spine BMD (LBMD; 7 studies; n = 247), and femoral neck BMD (FBMD; 2 studies; n = 78) Z-scores were performed. Overall effect sizes were: TBMD −0.45 (95% CI −0.61, −0.28); LBMD −0.70 (95% CI −0.82, −0.57); FBMD −0.96 (95% CI −1.42, −0.49). Definitions of osteopenia and osteoporosis were highly heterogeneous between studies and did not align with World Health Organization standards and the International Society for Clinical Densitometry positions on BMD measurement. Despite individual study findings of low BMD indicating higher risk of osteoporosis, pooled available data suggest reduction in BMD is not clinically important when using standard definitions of low BMD. Results from studies evaluating BTM are inconclusive. Phenylalanine concentration, vitamin D, PTH, and nutrient intake do not correlate with BMD or BTM. We recommend forthcoming studies use standard definitions of low BMD to determine clinical implications of BMD Z-scores below 0, explore cause of low BMD in the subset of patients with low BMD for chronological age (Z-score < −2) and assess fracture risk in patients with PKU. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13023-015-0232-y) contains supplementary material, which is available to authorized users. BioMed Central 2015-02-15 /pmc/articles/PMC4340652/ /pubmed/25758373 http://dx.doi.org/10.1186/s13023-015-0232-y Text en © Demirdas et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Demirdas, Serwet
Coakley, Katie E
Bisschop, Peter H
Hollak, Carla E M
Bosch, Annet M
Singh, Rani H
Bone health in phenylketonuria: a systematic review and meta-analysis
title Bone health in phenylketonuria: a systematic review and meta-analysis
title_full Bone health in phenylketonuria: a systematic review and meta-analysis
title_fullStr Bone health in phenylketonuria: a systematic review and meta-analysis
title_full_unstemmed Bone health in phenylketonuria: a systematic review and meta-analysis
title_short Bone health in phenylketonuria: a systematic review and meta-analysis
title_sort bone health in phenylketonuria: a systematic review and meta-analysis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340652/
https://www.ncbi.nlm.nih.gov/pubmed/25758373
http://dx.doi.org/10.1186/s13023-015-0232-y
work_keys_str_mv AT demirdasserwet bonehealthinphenylketonuriaasystematicreviewandmetaanalysis
AT coakleykatiee bonehealthinphenylketonuriaasystematicreviewandmetaanalysis
AT bisschoppeterh bonehealthinphenylketonuriaasystematicreviewandmetaanalysis
AT hollakcarlaem bonehealthinphenylketonuriaasystematicreviewandmetaanalysis
AT boschannetm bonehealthinphenylketonuriaasystematicreviewandmetaanalysis
AT singhranih bonehealthinphenylketonuriaasystematicreviewandmetaanalysis